![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Zhejiang Kinglyuan Pharmaceutical Co., Ltd. Shangyu Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Irbesartan, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2014-029 - Rev 00
This Chemical Type CEP, issued on April 17, 2015, remains in force until November 16, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 2465 associated with this CEP further emphasizes